Renovaro Operating Income

Renovaro (RENB) currently reports a operating income of $-130M as of March 2026. That compares with $-110M in the prior-year period — down 17.8% year over year. Use the charts on this page to explore Renovaro's operating income history and peer comparisons.

Renovaro's operating income decreased from $-110M to $-130M — a 17.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Renovaro reported $-130M in operating income as of March 2026. That compares with $-110M in the prior-year period — down 17.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Renovaro, and consider following RENB for alerts when major investors trade the stock.

Renovaro is classified in the Healthcare sector. On operating income, it currently shows $-130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RENB with unrelated industries.